See also this year's filing and all EDGAR filings for this company.
PDF Report 0000890821_2020_Enveric_Biosciences_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0000890821', 'EntityCommonStockSharesOutstanding': 7491544, 'Assets': 4096891, 'AssetsCurrent': 2279170, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 1817721, 'Liabilities': 681250, 'LiabilitiesAndStockholdersEquity': 4096891, 'LiabilitiesCurrent': 0, 'LiabilitiesNoncurrent': 0, 'NetIncome': -6864676, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 681250, 'remainder_LiabilitiesAndStockholdersEquity': 3415641, 'remainder_NetIncome': -4369958, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
Graph
Absolute values for 0000890821, Enveric Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,599,154 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 17,313,991 |
| 2 | PropertyPlantAndEquipmentNet | 83,128 |
| 3 | remainder_Assets | 8,879 |
| 4 | LiabilitiesCurrent | 14,383,605 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 31,978,191 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,815,659 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 7,278,879 |
| 11 | remainder_Revenues | 40,211,296 |
| 12 | remainder_NetIncome | -3,396,007 |
| 13 | remainder_ComprehensiveNetIncome | -461,050 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,005,152 |
| 1 | Liabilities | 14,383,605 |
| 2 | Expenses | 51,072,729 |
| 3 | Revenues | 40,211,296 |
| 4 | StockholdersEquity | 10,621,547 |
| 5 | NetIncome | -14,257,440 |
| 6 | ComprehensiveNetIncome | -14,487,965 |
| 7 | BaseVar | 67,264,920 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.440 |
| 9 | EconomicCapitalRatio | 1.83 |